ImmuCell Corp. (ICCC)
9.84
-0.06
(-0.61%)
USD |
NASDAQ |
Sep 08, 16:00
ImmuCell Total Liabilities (Quarterly) : 15.26M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.26M |
| March 31, 2026 | 14.97M |
| December 31, 2025 | 15.48M |
| September 30, 2025 | 15.93M |
| June 30, 2025 | 16.85M |
| March 31, 2025 | 16.63M |
| December 31, 2024 | 17.58M |
| September 30, 2024 | 18.04M |
| June 30, 2024 | 18.40M |
| March 31, 2024 | 18.41M |
| December 31, 2023 | 18.82M |
| September 30, 2023 | 18.53M |
| June 30, 2023 | 17.15M |
| March 31, 2023 | 14.96M |
| December 31, 2022 | 14.48M |
| September 30, 2022 | 14.42M |
| June 30, 2022 | 13.43M |
| March 31, 2022 | 13.33M |
| December 31, 2021 | 11.89M |
| September 30, 2021 | 11.77M |
| June 30, 2021 | 11.46M |
| March 31, 2021 | 11.75M |
| December 31, 2020 | 12.08M |
| September 30, 2020 | 11.97M |
| June 30, 2020 | 12.38M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.06M |
| December 31, 2019 | 9.701M |
| September 30, 2019 | 9.659M |
| June 30, 2019 | 9.764M |
| March 31, 2019 | 10.23M |
| December 31, 2018 | 10.99M |
| September 30, 2018 | 10.56M |
| June 30, 2018 | 9.927M |
| March 31, 2018 | 10.14M |
| December 31, 2017 | 10.70M |
| September 30, 2017 | 9.336M |
| June 30, 2017 | 7.866M |
| March 31, 2017 | 4.965M |
| December 31, 2016 | 4.975M |
| September 30, 2016 | 4.171M |
| June 30, 2016 | 4.267M |
| March 31, 2016 | 4.059M |
| December 31, 2015 | 3.987M |
| September 30, 2015 | 3.925M |
| June 30, 2015 | 1.339M |
| March 31, 2015 | 1.486M |
| December 31, 2014 | 1.794M |
| September 30, 2014 | 1.617M |
| June 30, 2014 | 1.664M |
| March 31, 2014 | 1.724M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 46.63M |
| Shareholders Equity (Quarterly) | 31.37M |
| Debt to Equity Ratio | 0.3967 |
| Current Ratio | 4.752 |
| Net Debt Paydown Yield | 0.48% |